Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 26, 2023; 11(27): 6455-6475
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6455
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6455
No. of studies | No. of patients | Egger's test | Begg's test (continuity corrected) | ||||
LRR | ORR | t | P > |t| | z | P > |z| | ||
No. LNH | 17 | 799 | 1209 | -5.1 | < 0.001 | 0.37 | 0.711 |
Operation time | 16 | 564 | 764 | 1.57 | 0.139 | 0.86 | 0.392 |
Blood loss | 14 | 489 | 689 | -2.18 | 0.050 | 1.86 | 0.063 |
POLS | 17 | 799 | 1209 | -3.03 | 0.008 | 0.04 | 0.967 |
R0 rate | 8 | 1609 | 1705 | 1.64 | 0.162 | 0.00 | 1.000 |
Complications | 15 | 511 | 703 | -1.67 | 0.119 | 1.29 | 0.198 |
Complications (Clavien-Dindo 3-4) | 8 | 244 | 245 | -1.85 | 0.162 | 0.73 | 0.462 |
OS | 15 | 1299 | 1936 | 0.3 | 0.767 | 0.68 | 0.499 |
TFS | 10 | 339 | 338 | -1.04 | 0.329 | 0.36 | 0.721 |
Ref. | Year | Country | Study design | NOS | Group | Patient (n) | Age | F/M | T stage/TNM stage(n) | Follow-up (mo) |
Agarwal et al[32] | 2015 | India | Retrospective | 7 | LRR | 24 | 44 (21-61) | 17/7 | Ⅰ: 3; Ⅱ: 10; Ⅲ: 11 | 18 (6-34) |
ORR | 46 | 49 (23-70) | 34/12 | Ⅰ: 5; Ⅱ: 10; Ⅲ: 31 | ||||||
Feng et al[33] | 2019 | China | Retrospective | 7 | LRR | 41 | 64 ± 14 | 17/24 | Tis: 9; T1: 10; T2: 14; T3: 8 | 12 (2-93) |
ORR | 61 | 66 ± 10 | 22/39 | Tis: 4; T1: 9; T2: 1 32; T3: 16 | ||||||
Itano et al[34] | 2015 | Japan | Retrospective | 6 | LRR | 16 | 68.1 ± 19.9 | 7/9 | T1: 3; T2: 13 | 37 |
ORR | 14 | 71.5 ± 13.2 | 9/5 | T1-T2: 14 | 48 | |||||
Jang et al[35] | 2019 | Korea | Retrospective | 7 | LRR | 55 | 70.1 ± 8.1 | 36/19 | T2: 55 | 35.2 (3-139) |
ORR | 44 | 65.5 ± 10.5 | 21/23 | T2: 44 | 38.6 (4-160) | |||||
Nag et al[36] | 2019 | India | Retrospective | 7 | LRR | 30 | 49.6 ± 12.8 | 27/3 | T1: 8; T2: 8; T3: 8; T4: 2 | NA |
ORR | 38 | 49 ± 10.1 | 23/15 | T1: 6; T2: 17; T3: 15; T4: 0 | NA | |||||
Ong et al[37] | 2017 | United States | Retrospective | 6 | LRR | 623 | 70 (61-79) | 442/181 | T1 + T2: 461; T3: 146; UKN: 16 | NA |
ORR | 882 | 587/295 | T1 + T2: 469; T3: 374; UKN: 39 | NA | ||||||
Vega et al[38] | 2019 | United StatesChile | Retrospective | 8 | LRR | 65 | 68 (59-76) | 49/141 | T1: 14; T2: 43; T3: 8 | Survivors: 70.8 (95%CI: 53.6 to 87.3) |
ORR | 190 | 11/54 | T1: 5; T2: 126; T3: 39 | |||||||
Cao et al[46] | 2021 | China | Retrospective | 8 | LRR | 53 | 61 (48-77) | 35 | T1b: 3; T2: 50 | NA |
ORR | 61 | 64 (39-79) | 47 | T1b: 5; T2: 56 | NA | |||||
Dou et al[48] | 2022 | China | Retrospective | 7 | LRR (PSM) | 30 | > 60: 21 | 23 | T2: 9; T3: 21 | NA |
ORR (PSM) | 30 | > 60: 19 | 25 | T2: 10; T3: 20 | NA | |||||
Lee et al[43] | 2022 | Korea | Retrospective | 8 | LRR | 20 | 71.85 ± 9.11 | 15 | T1: 4; T2: 12; T3: 4 | NA |
ORR | 24 | 68.08 ± 10.64 | 13 | T1: 5; T2: 16; T3: 3 | NA | |||||
Navarro et al[41] | 2020 | Korea | Retrospective | 7 | LRR (PSM) | 43 | 66.7 ± 10.3 | 18 | T2: 43 | 32 (2-125) |
ORR (PSM) | 43 | 65.4 ± 7.6 | 15 | T2: 43 | ||||||
Regmi et al[40] | 2020 | China | Retrospective | 7 | LRR | 20 | > 70y: 4 | 13 | T1b: 10; T2: 10 | 21.28 (12-29) |
ORR | 30 | > 70y: 3 | 19 | T1b: 13; T2: 17 | 20.4 (12.25-29.50) | |||||
Huang et al[44] | 2022 | China | Retrospective | 8 | LRR (PSM) | 35 | 58.7 ± 10.5 | 19 | T3: 35 | NA |
ORR (PSM) | 35 | 60.4 ± 10.6 | 18 | T3: 35 | NA | |||||
D'Silva et al[45] | 2021 | China | Retrospective | 7 | LRR (PSM) | 12 | 68.5 ± 10.56 | 7 | T2: 7;T3: 9 | 21.5 (9-80) |
ORR (PSM) | 12 | 67.5 ± 12.88 | 7 | T2: 5;T3: 3 | ||||||
Lee et al[42] | 2022 | Korea | Retrospective | 8 | LRR (PSM) | 56 | 62.0 ± 13.7 | 27 | T2: 56 | 26.2 |
ORR (PSM) | 56 | 62.5 ± 15.0 | 28 | T2: 56 | ||||||
Wang et al[39] | 2020 | China | Retrospective | 8 | LRR | 45 | 62.6 (45-76) | 29 | Tb: 30; T2: 15 | 38 (3-84) |
ORR | 61 | 65.2 (51-82) | 37 | Tb: 35;T2: 26 | 33 (6-72) | |||||
AlMasri et al[49] | 2020 | United States | Retrospective | 8 | LRR | 235 | 66.1 ± 11.8 | 64 | I: 24; II: 78; III: 133 | NA |
ORR | 445 | 65.8 ± 11.2 | 294 | I: 29; II: 114; III: 302 | NA | |||||
Cho et al[47] | 2022 | Korea | Retrospective | 7 | LRR (PSM) | 19 | 69.9 ± 9.1 | 11 | T2: 19 | 26 |
ORR (PSM) | 19 | 66.7 ± 7.8 | 7 | T2: 19 | 70 |
Ref. | Group | Pts | No. LNH | R0 margin(n) | Operation time (min) | Blood loss (mL) | POLS | Complications | Complications(Clavien-Dindo 3-4) |
Agarwal et al[32] | LRR | 24 | 12.5 ± 5.4 | NA | 270 (180-340) | 200 (100-850) | 5 (3-16) | 3 | NA |
ORR | 46 | 12.9 ± 5.4 | NA | 240 (180-360) | 275 (100-800) | 5 (3-17) | 8 | NA | |
Feng et al[33] | LRR | 41 | 5 ± 3 | 33 | 137 ± 92 | 358 ± 390 | 5 ± 3 | 3 | NA |
ORR | 61 | 5 ± 3 | 47 | 168 ± 51 | 386 ± 391 | 11 ± 5 | 6 | NA | |
Itano et al[34] | LRR | 16 | 12.6 ± 3.1 | NA | 368 ± 73 | 152 ± 90 | 9.1 ± 1.6 | 1 | NA |
ORR | 14 | 10.2 ± 4.0 | NA | 352 ± 75 | 777 ± 392 | 21.6 ± 9.0 | 3 | NA | |
Jang et al[35] | LRR | 55 | 7.6 ± 3.4 | NA | 231.0 ± 95.2 | 225.1 ± 328.6 | 5.8 ± 5.3 | 7 | 4 |
ORR | 44 | 9.9 ± 6.8 | NA | 252.5 ± 76.1 | 310.5 ± 260.9 | 9.5 ± 4.8 | 6 | 3 | |
Nag et al[36] | LRR | 30 | 11.9 ± 5.2 | 30 | 286.5 ± 71.6 | 158.6 ± 85.7 | 6.4 ± 3.1 | 5 | 0 |
ORR | 38 | 12.7 ± 4.2 | 37 | 274.2 ± 96.3 | 219.4 ± 87.7 | 9 ± 8.0 | 12 | 5 | |
Ong et al[37] | LRR | 623 | NA | 484 | NA | NA | NA | NA | NA |
ORR | 882 | NA | 664 | NA | NA | NA | NA | NA | |
Vega et al[38] | LRR | 65 | 6 (0-19) | 62 | 240 (120-275) | 300 (30-1200) | 4 (2-18) | 12 | NA |
ORR | 190 | 6 (0-27) | 172 | 240 (60-600) | 200 (50-2000) | 6 (1-52) | 38 | NA | |
Cao et al[46] | LRR | 53 | 6 (1-16) | NA | 238.4 | 257 ± 6.3 | 10.4 ± 18.6 | NA | NA |
ORR | 61 | 8 (1-42) | NA | 215.7 | 256.2 ± 6.3 | 11.3 ± 18.6 | NA | NA | |
Dou et al[48] | LRR (PSM) | 30 | 10.12 ± 0.90 | NA | 328.12 ± 21.53 | 256.74 ± 39.21 | 10.43 ± 0.97 | 6 | 3 |
ORR (PSM) | 30 | 7.92 ± 0.57 | NA | 245.82 ± 15.18 | 484.36 ± 64.67 | 14.23 ± 1.07 | 4 | 2 | |
Lee et al[43] | LRR | 20 | 5.75 ± 3.54 | 19 | 186.60 ± 88.14 | 320.00 ± 451.72 | 10.95 ± 4.82 | 2 | 2 |
ORR | 24 | 6.75 ± 4.17 | 23 | 231.67 ± 82.97 | 593.75 ± 912.04 | 12.80 ± 4.87 | 5 | 5 | |
Navarro et al[41] | LRR (PSM) | 43 | 6.12 ± 5.78 | NA | 139.05 ± 97.09 | 71.63 ± 178.77 | 6.05 ± 9.846 | 0 | 0 |
ORR(PSM) | 43 | 11.93 ± 7.03 | NA | 211.16 ± 91.36 | 208.14 ± 242.165 | 12.58 ± 5.504 | 4 | 0 | |
Regmi et al[40] | LRR | 20 | 5.4 ± 3.5 | 20 | 258.25 ± 72.50 | 242 ± 108.5 | 6.2 ± 2.4 | 3 | NA |
ORR | 30 | 5.8 ± 2.1 | 30 | 227.00 ± 59.81 | 401 ± 130.3 | 8.6 ± 2.3 | 6 | NA | |
Huang et al[44] | LRR (PSM) | 35 | 8.4 ± 4.6 | 34 | 245.0 (183.0-285.0) | 50.0 (50.0-150.0) | 6.0 (6.0-7.0) | 4 | 1 |
ORR (PSM) | 35 | 8.1 ± 3.9 | 33 | 160.0 (125.0-230.0) | 50.0 (50.0-150.0) | 7.0 (6.0-8.0) | 6 | 2 | |
Silva et al[45] | LRR (PSM) | 12 | 6.5 (4-9.5) | NA | 237.5 (120-520) | 300 (150-1750) | 4.5 (2-12) | 1 | 0 |
ORR (PSM) | 12 | 8.5 (4.5-14.5) | NA | 272.5 (180-560) | 275 (100-1800) | 8 (5-32) | 4 | 0 | |
Lee et al[42] | LRR (PSM) | 56 | 4.6 ± 4.1 | NA | 171.7 ± 64.1 | NA | 5.7 ± 4.2 | 4 | NA |
ORR (PSM) | 56 | 6.9 ± 4.9 | NA | 98.0 ± 53.2 | NA | 9.8 ± 4.9 | 7 | NA | |
Wang et al[39] | LRR | 45 | 19.8 ± 7.9 | NA | 115 ± 32.5 | 100 ± 25.4 | 3.5 ± 1.9 | 3 | NA |
ORR | 61 | 17.3 ± 5.7 | NA | 100 ± 20.4 | 200 ± 45.6 | 5.6 ± 2.7 | 8 | NA | |
AlMasri et al[49] | LRR | 235 | 6.5 ± 14.6 | 195 | NA | NA | 7.0 ± 13.0 | NA | NA |
ORR | 445 | 6.7 ± 13.5 | 348 | NA | NA | 8.8 ± 10.9 | NA | NA | |
Cho et al[47] | LRR (PSM) | 19 | 5.3 ± 6.6 | NA | 218.9 ± 145.0 | NA | 8.4 ± 5.9 | 4 | 0 |
ORR (PSM) | 19 | 7.3 ± 5.5 | NA | 316.8 ± 80.3 | NA | 14.4 ± 6.0 | 2 | 0 |
- Citation: He S, Yu TN, Cao JS, Zhou XY, Chen ZH, Jiang WB, Cai LX, Liang X. Laparoscopic vs open radical resection in management of gallbladder carcinoma: A systematic review and meta-analysis. World J Clin Cases 2023; 11(27): 6455-6475
- URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6455.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6455